Printer Friendly

ROCHESTER MEDICAL ANNOUNCES PRODUCT INNOVATIONS, RESULTS OF OPERATIONS

 ROCHESTER MEDICAL ANNOUNCES PRODUCT INNOVATIONS,
 RESULTS OF OPERATIONS
 STEWARTVILLE, Minn., Jan. 31 /PRNewswire/ -- Rochester Medical Corporation ("RMC") (NASDAQ: ROCM), Stewartville, at its annual meeting of shareholders yesterday, announced product innovations related to urological catheters, and its results of operations for the quarter ended Dec. 31, 1991.
 "We continue to explore applications for our manufacturing technology," said Anthony J. Conway, RMC's president. "These have resulted in development of a new model of our External Catheter for males who have not been able to use any external catheter in the past. We have filed patent application for this new product, and field trials preparatory to marketing will commence in the near future.
 "We are also pleased to announce other product innovations," he continued. "We have completed development of a prototype medicating Foley catheter and have filed for patent protection. This catheter is now being tested independently. When those tests are completed, we expect to begin the long process of qualifying this product with the FDA for commercial sale.
 "Our third product innovation is the prototype of a catheter which may have application to female incontinence. We have also filed patent application for this device, and we plan to continue our development efforts for this catheter."
 Conway also announced results of operations for the recently completed fiscal quarter. "Net sales were $100,445, resulting in a net loss of $(111,867) for the quarter. This represents initial sales to our exclusive licensee, Mentor Corporation. We expect the sales volume to grow as the External Catheter gains acceptance and as we begin to market Foley catheters."
 RMC develops and manufactures improved urological catheters including all silicone Foley catheters and all silicone male external catheters.
 -0- 1/31/92
 /CONTACT: Anthony J. Conway, president of RMC, 507-533-4203/
 (ROCM) CO: Rochester Medical Corporation ST: Minnesota IN: MTC SU: PDT ERN


GK -- NY008 -- 5465 01/31/92 08:30 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jan 31, 1992
Words:313
Previous Article:MOSCOW-McDONALD'S SERVES 30 MILLION CUSTOMERS IN TWO YEARS
Next Article:HORIZON GOLD TO RESTRUCTURE SWISS BONDS AND SETS CLOSING DATE FOR POTASH ACQUISITION
Topics:


Related Articles
FDA Approves Clinical Trials for Female Continence Device
Major Clinical Trial of Rochester Medical's Antibacterial Foley Catheter Completed At University Of Wisconsin
Rochester Medical Announces Fiscal 1996 Results, Fiscal 1997 Forecast
Rochester Medical Reports Operating Results, Developments
Rochester Medical Reports Sales, Developments
Rochester Medical Reports Third Quarter Fiscal 2001 Results; New Agreement With Mentor Corporation.
Frost & Sullivan Recognizes Rochester Medical With Product Innovation Award.
Rochester Medical Corporation Reports Fifth Consecutive Quarter of Record Sales.
Rochester Medical Reports Fourth Quarter and Annual Results.
Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters